Skip to main content
v2026.11,986 entries · CC-BY 4.0

Neuroethics: Definition, Scope and Governance Frameworks

Neuroethics defined through the NIH BRAIN Initiative’s eight principles and the OECD’s nine neurotechnology principles, with neural data and consent guidance.

Written and maintained by CASRAI Editorial Board

Published

On this page

Neuroethics is the consideration of the ethical, legal and societal implications of neuroscience research and of the tools and technologies it produces. In practice it is applied through published governance frameworks, most prominently the neuroethics guiding principles of the US NIH BRAIN Initiative (eight principles, 2018) and the OECD Recommendation on Responsible Innovation in Neurotechnology (nine principles, adopted December 2019). This guide sets out what each framework says and what it asks of research teams.

What is neuroethics?

The NIH BRAIN Initiative neuroethics paper by Greely and colleagues, published in the Journal of Neuroscience in December 2018, frames the field as attention to the ethical, legal and societal implications of neuroscience research. It does not offer a formal one-line definition, and neither does the OECD instrument; both are working documents that tell researchers, funders and governments what to attend to. That is the sense in which this page uses the term: a set of questions about safety, autonomy, privacy, misuse and fairness that arise whenever a study records, interprets or alters brain activity.

For the scientific background on the research itself, see what is neuroscience. For a large-scale example of a brain-research programme that raises these questions, see the Human Brain Project.

What does neuroethics cover?

Read together, the two frameworks show the scope in practice. Both start from safety. Both treat the privacy of data about the brain as a distinct concern. Both address people whose capacity to decide may be limited, the possibility of harmful uses of neuroscience tools, public dialogue, and the fair sharing of benefits. The OECD instrument adds oversight capacity, international collaboration and a culture of stewardship, because it addresses governments and innovators as well as laboratories.

The NIH BRAIN Initiative neuroethics guiding principles

Greely HT, Grady C, Ramos KM, Chiong W, Eberwine J, Farahany NA, Johnson LSM, Hyman BT, Hyman SE, Rommelfanger KS and Serrano EE published “Neuroethics Guiding Principles for the NIH BRAIN Initiative” in the Journal of Neuroscience (2018;38(50):10586-10588, DOI 10.1523/JNEUROSCI.2077-18.2018). It lists eight principles, quoted here in the authors’ wording:

  1. Make assessing safety paramount
  2. Anticipate special issues related to capacity, autonomy, and agency
  3. Protect the privacy and confidentiality of neural data
  4. Attend to possible malign uses of neuroscience tools and neurotechnologies
  5. Move neuroscience tools and neurotechnologies into medical or nonmedical uses with caution
  6. Identify and address specific concerns of the public about the brain
  7. Encourage public education and dialogue
  8. Behave justly and share the benefits of neuroscience research and resulting technologies

The principles are written for a specific research programme, but they are a usable checklist for any team working with human participants and neural recording or stimulation tools.

The OECD Recommendation on Responsible Innovation in Neurotechnology

The OECD Council adopted the Recommendation (instrument OECD/LEGAL/0457) in December 2019. It defines its key terms, and these definitions are useful for protocols and data policies:

  • Neurotechnology: “devices and procedures used to access, monitor, investigate, assess, manipulate, and/or emulate the structure and function of the neural systems of natural persons.”
  • Cognitive liberty: “the right to mental self-determination.”
  • Personal brain data: “data relating to the functioning or structure of the human brain of an identified or identifiable individual that includes unique information about their physiology, health, or mental states.”
  • Safety: “an acceptable level of probable benefits and risks to health.”

The nine principles, by title:

  1. Promote responsible innovation in neurotechnology to address health challenges
  2. Prioritise assessing safety in the development and use of neurotechnology
  3. Promote the inclusivity of neurotechnology for health
  4. Foster scientific collaboration in neurotechnology innovation across countries, sectors, and disciplines
  5. Enable societal deliberation on neurotechnology
  6. Enable the capacity of oversight and advisory bodies to address novel issues in neurotechnology
  7. Safeguard personal brain data and other information gained through neurotechnology
  8. Promote cultures of stewardship and trust in neurotechnology across the public and private sector
  9. Anticipate and monitor the potential unintended use and/or misuse of neurotechnology

NIH BRAIN principles and OECD principles compared

The data table below this guide pairs the two frameworks theme by theme: safety, capacity and consent, neural data privacy, misuse, public dialogue and benefit sharing. Two points stand out. First, safety is the first or second item in both lists, so a protocol that cannot show a safety assessment is weak under either framework. Second, only the OECD text sets out concrete data-subject options and oversight expectations, which the next sections draw on.

Protecting neural data

NIH principle 3 asks teams to protect the privacy and confidentiality of neural data. OECD principle 7 goes further and, in its sub-points, calls for options for people to access, amend and delete their personal data, and for protecting brain data from discrimination in legal processes, employment and insurance. A data management plan for a study that records brain activity should therefore state how identifiable neural recordings are stored, who can access them, and what participants can request. The general techniques are covered in differential privacy.

NIH principle 2 and OECD principle 7 both point to autonomy. The OECD text asks for consent that is adequate to protect autonomy, including for people with limited decision-making capacity. Consent documents for neuroscience studies should be written with that in mind; the standard elements are in components of informed consent.

Oversight bodies

OECD principle 6 asks governments to enable oversight and advisory bodies to address novel issues, to encourage research into the ethical, legal and social dimensions of neurotechnology, and to ensure oversight bodies have multidisciplinary expertise. For institutions, that translates into ethics committees that can call on neuroscience, data protection and ethics expertise when a protocol involves brain recording or stimulation.

Misuse and dual use

NIH principle 4 and OECD principle 9 both ask researchers to anticipate how tools might be misused. Teams can record this in the risk section of a protocol and revisit it when a tool moves from a laboratory setting towards clinical or commercial use, the caution that NIH principle 5 describes.

A practical checklist for research teams

The frameworks do not prescribe procedures, but their principles translate into questions a team can answer in a protocol, a data management plan or an ethics submission:

  • Safety: is there a documented assessment of the benefits and risks to health of the recording or stimulation tool, as both frameworks place safety first or second?
  • Capacity and autonomy: does the consent process address participants whose decision-making capacity may be limited (NIH principle 2; OECD principle 7)?
  • Neural data: does the data plan treat brain recordings from identifiable people as personal brain data, with options to access, amend and delete (OECD principle 7)?
  • Misuse: does the risk section consider malign or unintended uses of the tool (NIH principle 4; OECD principle 9)?
  • Public dialogue and benefit sharing: is there a plan to engage the public and to share benefits fairly (NIH principles 6 to 8; OECD principle 5)?

Common misunderstandings

  • Neuroethics is not a single law. The two frameworks discussed here are guidance: principles and recommendations, not statutes. Binding obligations on consent, data protection and human-subjects review come from the rules that apply to your institution and jurisdiction.
  • It is not limited to implants. The OECD definition of neurotechnology covers devices and procedures that access, monitor, investigate, assess, manipulate or emulate neural systems, so recording tools are within scope as well as stimulation.
  • Brain data is not automatically anonymous. The OECD definition of personal brain data covers data relating to an identified or identifiable individual.
  • It is not only a clinical concern. NIH principle 5 explicitly names nonmedical uses, and OECD principle 9 covers unintended use and misuse.

Ethical review of animal studies follows a different framework; see animal research ethics.

Frequently asked questions

What is neuroethics in simple terms?

Neuroethics is the consideration of the ethical, legal and societal implications of neuroscience research and its tools, according to the NIH BRAIN Initiative neuroethics guiding principles published in 2018.

How many principles are in the NIH BRAIN Initiative neuroethics guidance?

Eight. They begin with making safety paramount and end with behaving justly and sharing the benefits of neuroscience research.

What is the OECD Recommendation on neurotechnology?

It is a Council instrument, OECD/LEGAL/0457, adopted in December 2019, with nine principles on responsible innovation in neurotechnology, from safety assessment to monitoring misuse.

What is personal brain data?

The OECD defines it as data relating to the functioning or structure of the human brain of an identified or identifiable individual that includes unique information about their physiology, health or mental states.

What is cognitive liberty?

In the OECD Recommendation, cognitive liberty is “the right to mental self-determination.”

Are these frameworks legally binding?

They are guidance for researchers, funders and governments. Legal duties on consent and data protection come from the laws and institutional policies that apply to a given study.

Sources

Data: NIH BRAIN Initiative and OECD neurotechnology principles matched by theme

Each row pairs a theme with the closest principle in the NIH BRAIN Initiative neuroethics guiding principles (2018) and the OECD Recommendation on Responsible Innovation in Neurotechnology (2019); pairings are editorial matches, principle wording is quoted from the two sources.

Period covered: 2018/2019.

NIH BRAIN Initiative and OECD neurotechnology principles matched by theme
ThemeNIH BRAIN Initiative principle (2018)OECD Recommendation principle (2019)
SafetyMake assessing safety paramountPrioritise assessing safety in the development and use of neurotechnology
Capacity, autonomy and consentAnticipate special issues related to capacity, autonomy, and agencyPrinciple 7 sub-point (b): consent adequate to protect autonomy, including limited decision-making capacity
Privacy of neural dataProtect the privacy and confidentiality of neural dataSafeguard personal brain data and other information gained through neurotechnology
MisuseAttend to possible malign uses of neuroscience tools and neurotechnologiesAnticipate and monitor the potential unintended use and/or misuse of neurotechnology
Cautious translation to useMove neuroscience tools and neurotechnologies into medical or nonmedical uses with cautionPromote responsible innovation in neurotechnology to address health challenges
Public concerns and dialogueIdentify and address specific concerns of the public about the brain; Encourage public education and dialogueEnable societal deliberation on neurotechnology
Fair sharing of benefitsBehave justly and share the benefits of neuroscience research and resulting technologiesPromote the inclusivity of neurotechnology for health
Oversight capacityNo matching principleEnable the capacity of oversight and advisory bodies to address novel issues in neurotechnology
Collaboration and stewardshipNo matching principleFoster scientific collaboration in neurotechnology innovation across countries, sectors, and disciplines; Promote cultures of stewardship and trust in neurotechnology across the public and private sector

Sources

Compiled by CASRAI from the sources above. Free to reuse under CC BY 4.0 with attribution.

Follow CASRAI

Research-administration guidance, standards updates and independent tool reviews.

Ask CASRAI · free to try

Ask about Neuroethics: Definition, Scope and Governance Frameworks

2 free questions a day, no account.

An AI assistant for research: funder rules, compliance, methods and publishing. It links the sources behind its answers and labels answers that come from a web search.

Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.

Works on this site and inside Claude, Cursor and the AI tools you already use.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays open to read, with no account and no card.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →